World News

Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition

https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c

Proceedings of the National Academy of Sciences, Volume 122, Issue 52, December 2025. <br/>SignificanceWe provide the example of cancer cell reversion to quiescent neuronal cells by CBP/p300 small molecule inhibitors using human Merkel cell carcinoma (MCC), a cancer addicted to expression of the Merkel cell polyomavirus (MCV) T antigen …

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button